Carl Zeiss Meditec AG (AFX.DE) — Quality & forensics

As of 2026-08-06 — refreshed nightly. Closelook readings from an investment research diary, not ratings or advice.

The Closelook module scores

48 /100 composite · 7 modules · general weight set

Valuation 85
Quality 36
Growth 33
Balance sheet 43
Cash quality 54
Capital allocation 50
Momentum 41

Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.

Financial forensics — the academic screens

2.95 Altman Z-Score

Sits in the grey zone (1.81–2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.

8/9 Piotroski F-Score

Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.

-2.42 Beneish M-Score

Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.

Continue: the AFX.DE chart & overview

FAQ · from the current data · as of 2026-08-06

Quick answers

What is Carl Zeiss Meditec AG's Closelook quality reading?

The composite reads 48/100 across 7 modules, as of 2026-08-06: valuation 85, quality 36, growth 33, balance sheet 43, cash quality 54, capital allocation 50, momentum 41. Closelook scores are research diary readings, not ratings or investment advice.

What is Carl Zeiss Meditec AG's Altman Z-Score?

2.95, which sits in the grey zone (1.81–2.99) as of 2026-08-06. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.

What is Carl Zeiss Meditec AG's Piotroski F-Score?

8 of 9, as of 2026-08-06. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.

What does Carl Zeiss Meditec AG's Beneish M-Score indicate?

-2.42 — below the −1.78 manipulation-risk threshold, as of 2026-08-06. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.